WELCOME TO THE CIMEDLIFE
Introducing a novel genre in chronic disease management
Our Company
Fast Growing Pharma Company
Composite Interceptive Med-Sciences Laboratories Private limited (CIMED) is one of the first companies to scientifically develop polymolecular formulations for better management of Chronic and lifestyle related disorders. We utilize a composite pharmacology and soft targeting approach towards control of progression and management of these conditions. This new genre of medicine is called Interceptive medicine. Our R&D focus also involves orphan areas of medicine where currently there is not standard of care treatments.
Our Focus
SCOPE OF SERVICES
PRODUCT DEVELOPMENT
RESEARCH AND DEVELOPMENT SERVICES
Our Values
To become global leaders in Interceptive Systems Medicine
01.
Innovation
Formulation Development and R&D services
02.
Teamwork
End to End Clinical research services
03.
Sustainable
Production standardization and scale-up Manufacturing services
Our Mission
To become a globally recognized enterprise creating knowledge base to aid discovery, research & development of composite pharmaceutics, products for interceptive healthcare, models of systems medicine to address unmet medical needs of chronic diseases.
To enable patients to return to normal life by pre-empting disease progression using a new genre of CIMED Interceptive therapeutics